C4 Therapeutics, Inc. (CCCC)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $22k
- Jan 16 · No plan
- Form 4 sales
- 26
- On record
- Form 144 notices
- 9
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Aug 14, 2026Notice
Mossler Mark, Officer, filed a notice to sell 4,139 shares
$18k4,139 shares
- Aug 14, 2026Notice
Geldmacher Jay L, Former REZI CEO, filed a notice to sell 82,563 shares
$1.9M82,563 shares
- Aug 13, 2026Notice
Mossler Mark, Officer, filed a notice to sell 15,000 shares
$61k15,000 shares
- Aug 12, 2026Notice
Mossler Mark, Officer, filed a notice to sell 19,519 shares
$77k19,519 shares
- May 28, 2026Notice
Mossler Mark, Former Section 16 Officer, filed a notice to sell 9,087 shares
$35k9,087 shares
- Mar 9, 2026Notice
Siegel Jolie, Officer, filed a notice to sell 101,175 shares
$379k101,175 shares
- Jan 16, 2026No plan
Reyno Leonard, Chief Medical Officer, sold 6% of their holdings
$22k10,000 shares at $2.22
- Feb 18, 2025Routine
Boyle Scott N, Chief Business Officer, sold 1.1% of their holdings
$4k1,159 shares at $3.15
- Nov 18, 2024Notice
Salter Malcolm, Director, filed a notice to sell 13,000 shares
$55k13,000 shares
- Oct 18, 2024Notice
Salter Malcolm, Director, filed a notice to sell 13,000 shares
$83k13,000 shares
Every transaction
Loading transactions…
Sales, notices and lockups (35)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aug 14, 2026 | Mossler Mark | CCCC | Officer | Form 144 notice | 4,139 | $18k | Notice | SEC | |
| Aug 14, 2026 | Aug 14, 2026 | Geldmacher Jay L | CCCC | Former REZI CEO | Form 144 notice | 82,563 | $1.9M | Notice | SEC | |
| Aug 13, 2026 | Aug 13, 2026 | Mossler Mark | CCCC | Officer | Form 144 notice | 15,000 | $61k | Notice | SEC | |
| Aug 12, 2026 | Aug 12, 2026 | Mossler Mark | CCCC | Officer | Form 144 notice | 19,519 | $77k | Notice | SEC | |
| May 28, 2026 | May 28, 2026 | Mossler Mark | CCCC | Former Section 16 Officer | Form 144 notice | 9,087 | $35k | Notice | SEC | |
| Mar 9, 2026 | Mar 9, 2026 | Siegel Jolie | CCCC | Officer | Form 144 notice | 101,175 | $379k | Notice | SEC | |
| Jan 16, 2026 | Jan 16, 2026 | Reyno Leonard | CCCC | Chief Medical Officer | Form 4 sale | 10,000 | $22k | 6.0% | No plan | SEC |
| Feb 18, 2025 | Feb 18, 2025 | Boyle Scott N | CCCC | Chief Business Officer | Form 4 sale | 1,159 | $4k | 1.1% | Routine | SEC |
| Nov 18, 2024 | Nov 18, 2024 | Salter Malcolm | CCCC | Director | Form 144 notice | 13,000 | $55k | Notice | SEC | |
| Oct 18, 2024 | Oct 18, 2024 | Salter Malcolm | CCCC | Director | Form 144 notice | 13,000 | $83k | Notice | SEC | |
| Oct 11, 2024 | Oct 11, 2024 | Salter Malcolm | CCCC | Director | Form 144 notice | 8,561 | $46k | Notice | SEC | |
| Jan 4, 2022 | Jan 5, 2022 | Crystal Adam | CCCC | Chief Medical Officer | Form 4 sale | 15,000 | $475k | 50.0% | Unusual | SEC |
| Dec 17, 2021 | Dec 17, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $23k | 6.4% | Plan not stated | SEC |
| Nov 19, 2021 | Nov 19, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $30k | 6.1% | Plan not stated | SEC |
| Oct 15, 2021 | Oct 15, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $34k | 5.7% | Plan not stated | SEC |
| Oct 1, 2021 | Oct 5, 2021 | Crystal Adam | CCCC | Chief Medical Officer | Form 4 sale | 15,000 | $681k | 100.0% | Unusual | SEC |
| Sep 27, 2021 | Sep 29, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 1,850 | $93k | 0.4% | Plan not stated | SEC |
| Sep 24, 2021 | Sep 24, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 32,743 | $1.6M | 6.1% | Plan not stated | SEC |
| Sep 21, 2021 | Sep 21, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 21,161 | $1.1M | 3.9% | Plan not stated | SEC |
| Sep 17, 2021 | Sep 21, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $38k | 5.5% | Plan not stated | SEC |
| Sep 16, 2021 | Sep 16, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 81,676 | $4M | 13.8% | Unusual | SEC |
| Sep 13, 2021 | Sep 14, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 9,210 | $461k | 1.5% | Plan not stated | SEC |
| Sep 10, 2021 | Sep 14, 2021 | Siegel Jolie | CCCC | Chief Legal Officer | Form 4 sale | 12,500 | $625k | 100.0% | Unusual | SEC |
| Aug 20, 2021 | Aug 24, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $31k | 5.2% | Plan not stated | SEC |
| Aug 3, 2021 | Aug 5, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 14,407 | $651k | 14.0% | Plan not stated | SEC |
| Aug 3, 2021 | Aug 5, 2021 | Fisher Stewart | CCCC | Chief Scientific Officer | Form 4 sale | 17,057 | $768k | 42.9% | Unusual | SEC |
| Aug 2, 2021 | Aug 2, 2021 | Prokupets Elena | CCCC | Director | Form 4 sale | 15,593 | $702k | 13.2% | Plan not stated | SEC |
| Aug 2, 2021 | Aug 2, 2021 | Fisher Stewart | CCCC | Chief Scientific Officer | Form 4 sale | 68,315 | $3.1M | 63.2% | Unusual | SEC |
| Jul 29, 2021 | Aug 2, 2021 | Siegel Jolie | CCCC | Chief Legal Officer | Form 4 sale | 12,500 | $563k | 100.0% | Unusual | SEC |
| Jul 29, 2021 | Aug 2, 2021 | Crystal Adam | CCCC | Chief Medical Officer | Form 4 sale | 15,000 | $675k | 100.0% | Unusual | SEC |
| Jul 16, 2021 | Jul 19, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $28k | 5.0% | Plan not stated | SEC |
| Jul 1, 2021 | Jul 6, 2021 | Crystal Adam | CCCC | Chief Medical Officer | Form 4 sale | 15,000 | $570k | 100.0% | Unusual | SEC |
| Jun 18, 2021 | Jun 21, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $28k | 4.8% | Plan not stated | SEC |
| May 21, 2021 | May 24, 2021 | Salter Malcolm | CCCC | Director | Form 4 sale | 755 | $28k | 4.6% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 6, 2021 | Crystal Adam | CCCC | Chief Medical Officer | Form 4 sale | 15,000 | $567k | 100.0% | Unusual | SEC |